ZA931109B - Tetrahydropyrimidine derivatives. - Google Patents

Tetrahydropyrimidine derivatives.

Info

Publication number
ZA931109B
ZA931109B ZA931109A ZA931109A ZA931109B ZA 931109 B ZA931109 B ZA 931109B ZA 931109 A ZA931109 A ZA 931109A ZA 931109 A ZA931109 A ZA 931109A ZA 931109 B ZA931109 B ZA 931109B
Authority
ZA
South Africa
Prior art keywords
tetrahydropyrimidine derivatives
tetrahydropyrimidine
derivatives
Prior art date
Application number
ZA931109A
Other languages
English (en)
Inventor
Ralf Plate
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of ZA931109B publication Critical patent/ZA931109B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/12—Nitrogen atoms not forming part of a nitro radical
    • C07D239/14—Nitrogen atoms not forming part of a nitro radical with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to said nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA931109A 1992-03-04 1993-02-17 Tetrahydropyrimidine derivatives. ZA931109B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200622 1992-03-04

Publications (1)

Publication Number Publication Date
ZA931109B true ZA931109B (en) 1993-09-22

Family

ID=8210467

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA931109A ZA931109B (en) 1992-03-04 1993-02-17 Tetrahydropyrimidine derivatives.

Country Status (11)

Country Link
US (1) US5470856A (xx)
EP (1) EP0559279A1 (xx)
JP (1) JPH05339245A (xx)
KR (1) KR930019640A (xx)
AU (1) AU661107B2 (xx)
CA (1) CA2090170A1 (xx)
FI (1) FI930934A (xx)
MX (1) MX9301178A (xx)
NO (1) NO930776L (xx)
NZ (1) NZ247037A (xx)
ZA (1) ZA931109B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19612504C2 (de) * 1996-03-29 2003-10-23 Boehringer Ingelheim Kg Neue Wirkstoffkompositionen
US8853219B2 (en) 2010-01-11 2014-10-07 Neurosolis, Inc. Compounds and compositions for cognition-enhancement, methods of making, and methods of treating
WO2012033956A1 (en) 2010-09-08 2012-03-15 Mithridion, Inc. Cognition enhancing compounds and compositions, methods of making, and methods of treating

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786648A (en) * 1986-12-08 1988-11-22 Warner-Lambert Company O-substituted tetrahydropyridine oxime cholinergic agents
IT1231237B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati eterociclici
IL97266A0 (en) * 1990-03-06 1992-05-25 Warner Lambert Co Azabicyclo and azacyclo oximes and amines,their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
NZ247037A (en) 1995-10-26
MX9301178A (es) 1993-09-01
AU3393293A (en) 1993-09-09
AU661107B2 (en) 1995-07-13
EP0559279A1 (en) 1993-09-08
FI930934A0 (fi) 1993-03-03
CA2090170A1 (en) 1993-09-05
NO930776L (no) 1993-09-06
US5470856A (en) 1995-11-28
KR930019640A (ko) 1993-10-18
FI930934A (fi) 1993-09-05
JPH05339245A (ja) 1993-12-21
NO930776D0 (no) 1993-03-03

Similar Documents

Publication Publication Date Title
ZA934603B (en) thiazolylvinylphenyl derivatives.
GR3029455T3 (en) 3-Aryl-4-hydroxy-3-dihydrofuranone derivatives.
EP0650356A4 (en) RAPAMYCIN DERIVATIVES.
EP0650489A4 (en) RAPAMYCINE DERIVATIVES.
EP0597463A3 (en) Thermotherapiesonde.
GR3030794T3 (en) Substituted thiazolidinedione derivatives.
EP0580285A3 (en) Auto-reclosers.
PH30897A (en) 1-5 Benzodiazepine derivatives.
EP0650357A4 (en) RAPAMYCINE DERIVATIVES.
ZA941137B (en) Substitutet azolone derivatives.
GB9305306D0 (en) Pyrrolo-pyridazione derivatives
EP0572808A3 (de) Antiblockierregelsystem.
GB9016800D0 (en) Tetrahydropyrimidine derivatives
AP9300595A0 (en) Intecticidal 5-substituted-2, 4-diaminopyrimidine derivatives
ZA929934B (en) Heterocyclic derivatives.
ZA928742B (en) Heterocyclic derivatives.
EP0668864A4 (en) SUBSTITUTED BIPHENYLMETHYLIMIDAZOPYRIDINES.
OA09716A (en) Benzoxaiole derivatives.
EP0599191A3 (en) Engine speed control circuit.
ZA938349B (en) Rapamycin derivatives.
EP0592354A3 (de) Vakuum-Zentrifuge.
ZA937988B (en) Substituted 1-H-3-aryl-pyrrolidine-2,4-dione derivatives
GB2271564B (en) Thioalkylthio carbacephalosporin derivatives
GB2270913B (en) Chlordifluoromethoxyphenyl derivatives
ZA931109B (en) Tetrahydropyrimidine derivatives.